Pharma Tech Conclave 2023

Chitkara University and DeepSynergy presents the Pharma Tech Conclave 2023. The conference will be held on 3rd Mar 2023 from 9:00 am to 5:00 pm IST at the Chitkara College of Pharmacy, Chitkara University, Chandigarh. The global pharmaceutical industry is undergoing transformational changes due to advancements in technological innovations that aim to fundamentally alter how patients…

BySenior EditorFebruary 22, 2023

EVENTS

Pharma IPR Conference 2023: The 12th Annual Pharma Intellectual Property Rights

The 12th edition of the Pharma IPR Conference organized by Informa Markets will be held from 1-3 March 2023 in Mumbai. This is the only conference in India's pharmaceutical industry that focuses on Intellectual Property. The aim of this conference is to bring together all stakeholders in the pharma sector to discuss and deliberate on…

BySenior EditorJanuary 30, 2023

EVENTS

Global PHT Expo & Summit 2023, An International Conference & Exhibition on Pharma, Healthcare & Technology

Weece Events is glad to invite you to attend the Global PHT Expo & Summit 2023 which is an International Conference & Exhibition on PHARMA, HEALTHCARE & TECHNOLOGY focusing on the Future of the Global Pharma & Healthcare Ecosystem in a digitally transforming world. The event is happening from 15-17th Feb 2023 at Hyatt Centric,…

BySenior EditorJanuary 25, 2023

EXCLUSIVE

Kyle Forcier, Senior Director of Life Sciences Product Marketing at Model N Shares Insights on How Model N Helps Life Sciences Companies Navigate Greater Compliance Pressure

Shots: Kyle Forcier gave a detailed view of the Spring 2022 product release by Model N and how it will be a practical solution for the Pharmaceutical and MedTech companies Kyle also spoke about Model N’s Revenue Cloud, which can empower MedTech Sales with better revenue recognition The interview gives a glimpse of Model N’s…

BySenior EditorJuly 11, 2022

THOUGHTSPOT

After Effects of Russia – Ukraine Conflict Over Pharma and Life Sciences Industry

Everywhere on TV, social media, digital print or print media we are hearing/ watching how Russia has invaded Ukraine. Russia and Ukraine are at war which is impacting not only both companies but also millions of lives globally. The situation has affected many areas of day-to-day life including a big burden on the healthcare system…

BySenior EditorMarch 2, 2022

INSIGHTS+

PharmaShots’ Key Highlights of First Quarter 2021

The first quarter of 2021 highlights new approvals, M&A, and the clinical data of COVID-19 vaccines. The companies expand their working in COVID-19 by targeting South African & Brazil variants along with other emerging variants Starting with the latest acquisition, Amgen acquired Five Prime for $1.9B, Jazz acquired JW while Boston acquired Preventice. This quarter…

ByRidhi RastogiApril 4, 2021

Announcements

PharmaShots Celebrates Successful Accomplishment of One Year

Shots: Team PharmaShots started their journey on 25 July 2018 and is proudly announcing their completion of one year, with many more to come. PharmaShots has published 1,238 news and articles till date We are grateful to all our subscribers for their affection towards PharmaShots and for subscribing our news alerts. We ensure to put…

BySenior EditorJuly 25, 2019

INSIGHTS+

Insights+: The US FDA New Drug Approvals in 2018

1. Janssen's Erleada (apalutamide) Receives FDA Approval for Non-Metastatic Castration-Resistant Prostate Cancer (NM-CRPC) Published: 14 Feb,2018 | Tags: Janssen, Erleada, apalutamide, Receives, FDA, Approval, Non-Metastatic Castration-Resistant Prostate Cancer, NM-CRPC 2. Helsinn's (fosnetupitant + palonosetron) Receives FDA Approval for Managing Chemotherapy-Induced Nausea and Vomiting (CINV) Published: 14 Feb,2018 | Tags: Helsins, fosnetupitant + palonosetron, Receives, FDA, Approval, Managing Chemotherapy-Induced Nausea and Vomiting,…

BySenior EditorMarch 4, 2019

INSIGHTS+

PharmaShots Year in Review: Biosimilars Approvals in 2018

THE US FDA APPROVALS 1. Pfizer's Retacrit (epoetin alfa-epbx, biosimilar) Receives FDA Approval for Anemia Published: 15 May, 2018 | Tags: Pfizer, Retacrit, epoetinalfa-epbx, biosimilar, Receives, FDA, Approval, Anemia 2. Pfizer's Nivestym (filgrastim-aafi, biosmilar) Receives FDA Approval for Neutropenia Published: 20 Jul, 2018 | Tags: (filgrastim-aafi approval biosmilar), Neutropenia, Nivestym, Pfizer, Receives, the US FDA 3. Sandoz's Hymiroz (adalimumab-adaz, biosimilar) Receives the US FDA…

BySaurabh ChaubeyJanuary 8, 2019

INSIGHTS+

PharmaShots’ Most Read News of 2018

PharmaShots' Most Read News of 2018 | Top 10 Pharma News of 2018 1. Celgene to Acquire Juno for its Cellular Immunotherapy & Hematology Portfolio Published: 22 Jan, 2018 | Tags: Celgene, Acquire, Juno, Cellular, Immunotherapy, Hematology Portfolio 2. Sanofi to Acquire Bioverativ for its Hemophilia Products Published: 22 Jan, 2018 | Tags: Sanofi, Acquire, Bioverativ, Treat,…

BySenior EditorJanuary 2, 2019

Pharma Tech Conclave 2023

Pharma IPR Conference 2023: The 12th Annual Pharma Intellectual Property Rights

Global PHT Expo & Summit 2023, An International Conference & Exhibition on Pharma, Healthcare & Technology

Kyle Forcier, Senior Director of Life Sciences Product Marketing at Model N Shares Insights on How Model N Helps Life Sciences Companies Navigate Greater Compliance Pressure

After Effects of Russia – Ukraine Conflict Over Pharma and Life Sciences Industry

PharmaShots’ Key Highlights of First Quarter 2021

PharmaShots Celebrates Successful Accomplishment of One Year

Insights+: The US FDA New Drug Approvals in 2018

PharmaShots Year in Review: Biosimilars Approvals in 2018

PharmaShots’ Most Read News of 2018

Contact US

FOLLOW US